The seroprevalence of Bartonella spp. in the blood of patients with musculoskeletal complaints and blood donors, Poland: a pilot study.
Adult
Aged
Antibodies, Bacterial
/ blood
Bacteremia
Bartonella
/ isolation & purification
Bartonella Infections
/ blood
Bites and Stings
Blood Donors
Female
Humans
Immunoglobulin G
/ immunology
Immunoglobulin M
/ immunology
Insect Bites and Stings
Male
Middle Aged
Musculoskeletal Diseases
/ blood
Pilot Projects
Poland
Risk Factors
Seroepidemiologic Studies
Bartonella spp.
Blood donors
Musculoskeletal symptoms
Journal
Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
23
01
2019
accepted:
15
04
2019
revised:
05
04
2019
pubmed:
23
5
2019
medline:
2
5
2020
entrez:
23
5
2019
Statut:
ppublish
Résumé
Bartonella spp. can cause a variety of diseases, such as lymphadenopathies, cat scratch disease, and trench fever, but can also give rise to many non-specific symptoms. No data exists regarding the prevalence of Bartonella spp. in patients with musculoskeletal complaints, nor among blood donors in Poland. The presence of anti-Bartonella IgM and IgG in the serum of blood donors (n = 65) (Lodz, Poland) and in the patients of the Department of Rheumatology Clinic (n = 40) suffering from musculoskeletal symptoms was tested by immunofluorescence. Blood samples were cultured on enriched media. Epidemiological questionnaires were used to identify key potential risk factors, such as sex, age, contact with companion animals, and bites from insects or animals. Altogether, 27 of the 105 tested subjects were seropositive for Bartonella henselae IgG (23%) and three for Bartonella quintana IgG (2.85%); IgMs against B. henselae were found in three individuals (2.85%), and IgMs against B. quintana were found in one (1.54%). No statistically significant difference was found between the prevalence of B. henselae in the blood of donors or patients and the presence of unexplained musculoskeletal complaints (23% vs 30%). Individuals who had kept or been scratched by cats were not more likely to be B. henselae seropositive (p > 0.01). Tick bites were more commonly reported in patients, but insignificantly (p > 0.01). This is the first report of a high seroprevalence of anti-Bartonella IgG in patients with musculoskeletal symptoms and in blood donors in Poland. The obtained results indicate that such seroprevalence may have a possible significance in the development of musculoskeletal symptoms, although it should be confirmed on a larger group of patients. Asymptomatic bacteremia might occur and pose a threat to recipients of blood from infected donors. Hence, there is a need for more detailed research, including molecular biology methods, to clarify the potential risk of Bartonella spp. being spread to immunocompromised individuals. • This is the first study presenting high seroprevalence of Bartonella spp. in Poland. • IgG and IgM antibodies against B. quintana were found in blood samples of blood donors.
Sections du résumé
BACKGROUND
BACKGROUND
Bartonella spp. can cause a variety of diseases, such as lymphadenopathies, cat scratch disease, and trench fever, but can also give rise to many non-specific symptoms. No data exists regarding the prevalence of Bartonella spp. in patients with musculoskeletal complaints, nor among blood donors in Poland.
METHODS
METHODS
The presence of anti-Bartonella IgM and IgG in the serum of blood donors (n = 65) (Lodz, Poland) and in the patients of the Department of Rheumatology Clinic (n = 40) suffering from musculoskeletal symptoms was tested by immunofluorescence. Blood samples were cultured on enriched media. Epidemiological questionnaires were used to identify key potential risk factors, such as sex, age, contact with companion animals, and bites from insects or animals.
RESULTS
RESULTS
Altogether, 27 of the 105 tested subjects were seropositive for Bartonella henselae IgG (23%) and three for Bartonella quintana IgG (2.85%); IgMs against B. henselae were found in three individuals (2.85%), and IgMs against B. quintana were found in one (1.54%). No statistically significant difference was found between the prevalence of B. henselae in the blood of donors or patients and the presence of unexplained musculoskeletal complaints (23% vs 30%). Individuals who had kept or been scratched by cats were not more likely to be B. henselae seropositive (p > 0.01). Tick bites were more commonly reported in patients, but insignificantly (p > 0.01).
CONCLUSION
CONCLUSIONS
This is the first report of a high seroprevalence of anti-Bartonella IgG in patients with musculoskeletal symptoms and in blood donors in Poland. The obtained results indicate that such seroprevalence may have a possible significance in the development of musculoskeletal symptoms, although it should be confirmed on a larger group of patients. Asymptomatic bacteremia might occur and pose a threat to recipients of blood from infected donors. Hence, there is a need for more detailed research, including molecular biology methods, to clarify the potential risk of Bartonella spp. being spread to immunocompromised individuals.
KEY POINTS
CONCLUSIONS
• This is the first study presenting high seroprevalence of Bartonella spp. in Poland. • IgG and IgM antibodies against B. quintana were found in blood samples of blood donors.
Identifiants
pubmed: 31115789
doi: 10.1007/s10067-019-04591-5
pii: 10.1007/s10067-019-04591-5
doi:
Substances chimiques
Antibodies, Bacterial
0
Immunoglobulin G
0
Immunoglobulin M
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2691-2698Références
Rev Argent Microbiol. 2018 Oct - Dec;50(4):365-368
pubmed: 29336912
Rev Chilena Infectol. 2016 Jun;33(3):355-7
pubmed: 27598290
Clin Microbiol Infect. 2016 Aug;22(8):735.e1-9
pubmed: 27237545
Pol J Microbiol. 2012;61(2):143-5
pubmed: 23163214
Clin Diagn Lab Immunol. 1998 Jul;5(4):486-90
pubmed: 9665953
Clin Dermatol. 2009 May-Jun;27(3):271-80
pubmed: 19362689
Transfusion. 2016 Jun;56(6 Pt 2):1556-9
pubmed: 26968530
FEMS Microbiol Rev. 2012 May;36(3):563-99
pubmed: 22229763
DNA Cell Biol. 2007 Sep;26(9):657-63
pubmed: 17678436
Parasit Vectors. 2017 Nov 7;10(1):553
pubmed: 29116007
Clin Microbiol Rev. 2017 Jul;30(3):709-746
pubmed: 28490579
J Clin Microbiol. 2013 Aug;51(8):2781-4
pubmed: 23740723
Diagn Microbiol Infect Dis. 2011 Dec;71(4):430-7
pubmed: 21996096
Comp Immunol Microbiol Infect Dis. 2012 Mar;35(2):93-102
pubmed: 22304899
J Clin Microbiol. 2005 Jun;43(6):2651-5
pubmed: 15956379
APMIS. 2018 Nov;126(11):831-837
pubmed: 30357961
Korean J Intern Med. 2017 May;32(3):530-535
pubmed: 28490714
Ticks Tick Borne Dis. 2016 Jul;7(5):763-767
pubmed: 26997137
Int J Med Microbiol. 2015 Oct;305(7):652-62
pubmed: 26422407
J Clin Microbiol. 2015 Mar;53(3):824-9
pubmed: 25540398
Vector Borne Zoonotic Dis. 2017 Jan;17(1):42-50
pubmed: 28055575
J Formos Med Assoc. 1998 Aug;97(8):569-72
pubmed: 9747069
J Clin Microbiol. 1993 Apr;31(4):872-81
pubmed: 7681847
PLoS Negl Trop Dis. 2016 Mar 21;10(3):e0004509
pubmed: 26999057
Epidemiol Infect. 2008 Dec;136(12):1712-6
pubmed: 18294428
PLoS Negl Trop Dis. 2015 Jan 15;9(1):e0003467
pubmed: 25590435
Zoonoses Public Health. 2017 Sep;64(6):485-490
pubmed: 28328183
J Vector Ecol. 2015 Jun;40(1):75-82
pubmed: 26047187
Ann N Y Acad Sci. 2006 Oct;1078:410-5
pubmed: 17114749
Mikrobiyol Bul. 2014 Jul;48(3):477-83
pubmed: 25052114
J Microbiol Immunol Infect. 2017 Apr;50(2):239-244
pubmed: 26051222
Rev Chilena Infectol. 2017 Dec;34(6):539-543
pubmed: 29488546
J Clin Microbiol. 1999 Dec;37(12):4034-8
pubmed: 10565926
Adv Exp Med Biol. 2017;1020:33-42
pubmed: 28405890
Am J Trop Med Hyg. 2002 May;66(5):622-7
pubmed: 12201602
Int J Infect Dis. 2016 May;46:61-3
pubmed: 27000538
Adv Pediatr. 1996;43:397-422
pubmed: 8794184
Rev Inst Med Trop Sao Paulo. 2002 Nov-Dec;44(6):325-30
pubmed: 12532216
Clin Rheumatol. 2017 Jul;36(7):1669-1675
pubmed: 28028681
Am J Public Health. 1993 Dec;83(12):1707-11
pubmed: 8259799
Scand J Infect Dis. 2005;37(10):723-30
pubmed: 16191889
Vector Borne Zoonotic Dis. 2018 Jun;18(6):291-296
pubmed: 29630475
Emerg Infect Dis. 2012 May;18(5):783-91
pubmed: 22516098